Effect of NAPDH oxidase inhibitors on lung fibroblast proliferation in systemic sclerosis

T. Hua-Huy (Paris, France), C. Nicco (Paris, France), J. Boucher (Paris, France), H. Vu-Ngoc (Paris, France), E. Tran-Van-Hoi (Paris, France), F. Batteux (Paris, France), A. Slama-Schwok (Jouy en Josas, France), A. Dinh-Xuan (Paris, France)

Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Session: Pulmonary fibrosis: from models to patients
Session type: Thematic Poster
Number: 992
Disease area: Interstitial lung diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Hua-Huy (Paris, France), C. Nicco (Paris, France), J. Boucher (Paris, France), H. Vu-Ngoc (Paris, France), E. Tran-Van-Hoi (Paris, France), F. Batteux (Paris, France), A. Slama-Schwok (Jouy en Josas, France), A. Dinh-Xuan (Paris, France). Effect of NAPDH oxidase inhibitors on lung fibroblast proliferation in systemic sclerosis. 992

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COX inhibition enhances remodelling processes in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

NADPH oxidase 4 deficiency protects from bleomycin-induced epithelial cell death and pulmonary fibrosis
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010


Effects of oral tolerance on neuronal nitric oxidase synthase expression on bronchial epithelial cells in a model of chronic pulmonary inflammation
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


PP125 – Glycogen synthase kinase-3 inhibition by CHIR99021 promotes alveolar epithelial cell proliferation and lung regeneration in acute lung injury
Source: ERS Lung Science Conference 2021
Year: 2021

Xanthine oxidase inhibitors reduce rhinovirus induced IL-8 and GRO-α production in bronchial epithelial cells
Source: Eur Respir J 2007; 30: Suppl. 51, 721s
Year: 2007

Role of the JAK/STAT pathway in activation of the xanthine dehydrogenase/oxidase in lung microvascular endothelial cells exposure to hypoxia
Source: Eur Respir J 2007; 30: Suppl. 51, 145s
Year: 2007

Combined inhibition of NADPH oxidase and inducible NOS in prevention of ischemia/reperfusion injury of the lung
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007


Increased alveolar concentration of nitric oxide is related to serum-induced lung fibroblast proliferation in scleroderma patients
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009


Hypoxia-dependent regulation of non-phagocytic NADPH oxidase NOX4 in the pulmonary vasculature
Source: Eur Respir J 2007; 30: Suppl. 51, 56s
Year: 2007

Statins inhibit human lung fibroblast production and activation of MMPs
Source: Eur Respir J 2007; 30: Suppl. 51, 692s
Year: 2007

Bromodomain inhibitor JQ1 attenuates TGF-beta-suppressed SOD2 expression and reduces proliferation in human primary pulmonary fibroblasts
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013

Effect of cyclooxygenase-2 inhibition on lung inflammation and hypoxia-inducible factor-1 signalling in COPD model
Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Year: 2017


NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009

PP216 – Glucocorticoids exacerbate TGFß1 mediated fibrotic signalling in lung fibroblasts by inhibition of metalloproteinase expression and activity
Source: ERS Lung Science Conference 2021
Year: 2021

Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Erythropoietin (EPO) inhibits the immunohistochemical expression of lysyl oxidase (LOX) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Localisation of NADPH oxidases and their role in hypoxia induced pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 804s
Year: 2006

Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice
Source: Eur Respir J 2014; 43: 1448-1458
Year: 2014



Inhibition of collagen cross-links by novel LOXL2 selective inhibitors in an in-vitro model of fibroblastic foci of IPF
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Signaling of angiopoietin-1 in human skeletal cells: role of NADPH oxidase
Source: Annual Congress 2008 - Respiratory muscle pathophysiology
Year: 2008